Literature DB >> 18697697

Access to medicines, BRICS alliances, and collective action.

Peter K Yu1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18697697     DOI： 10.1177/009885880803400210

Source DB:  PubMed          Journal:  Am J Law Med        ISSN： 0098-8588


× No keyword cloud information.
  5 in total

Review 1.  Essential drugs production in Brazil, Russia, India, China and South Africa (BRICS): opportunities and challenges.

Authors:  Zoheir Ezziane
Journal:  Int J Health Policy Manag       Date:  2014-11-06

2.  Compulsory patent licensing and local drug manufacturing capacity in Africa.

Authors:  Olasupo Ayodeji Owoeye
Journal:  Bull World Health Organ       Date:  2014-01-10       Impact factor: 9.408

3.  EMERGING AND TRANSITIONING COUNTRIES' ROLE IN GLOBAL HEALTH.

Authors:  Jennifer Prah Ruger; Nora Y Ng
Journal:  St Louis U J Health Law Policy       Date:  2010

4.  Understanding how domestic health policy is integrated into foreign policy in South Africa: a case for accelerating access to antiretroviral medicines.

Authors:  Simon Moeketsi Modisenyane; Stephen James Heinrich Hendricks; Harvey Fineberg
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

Review 5.  'BRICS without straw'? A systematic literature review of newly emerging economies' influence in global health.

Authors:  Andrew Harmer; Yina Xiao; Eduardo Missoni; Fabrizio Tediosi
Journal:  Global Health       Date:  2013-04-15       Impact factor: 4.185
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.